Correlation Between Sutro Biopharma and Dyadic International

Can any of the company-specific risk be diversified away by investing in both Sutro Biopharma and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sutro Biopharma and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sutro Biopharma and Dyadic International, you can compare the effects of market volatilities on Sutro Biopharma and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sutro Biopharma with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sutro Biopharma and Dyadic International.

Diversification Opportunities for Sutro Biopharma and Dyadic International

-0.83

Correlation Coefficient

Sutro Biopharma  Dyadic International

Pay attention - limited upside

The 3 months correlation between Sutro and Dyadic is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Sutro Biopharma and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Sutro Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sutro Biopharma are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Sutro Biopharma i.e., Sutro Biopharma and Dyadic International go up and down completely randomly.

Pair Corralation between Sutro Biopharma and Dyadic International

Given the investment horizon of 90 days Sutro Biopharma is expected to generate 0.73 times more return on investment than Dyadic International. However, Sutro Biopharma is 1.37 times less risky than Dyadic International. It trades about 0.05 of its potential returns per unit of risk. Dyadic International is currently generating about -0.1 per unit of risk. If you would invest  193.00  in Sutro Biopharma on October 25, 2024 and sell it today you would earn a total of  4.00  from holding Sutro Biopharma or generate 2.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sutro Biopharma  vs.  Dyadic International

Sutro Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sutro Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Dyadic International

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dyadic International are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Dyadic International demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sutro Biopharma and Dyadic International

The main advantage of trading using opposite Sutro Biopharma and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sutro Biopharma position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.

The idea behind Sutro Biopharma and Dyadic International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.